October 2025
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
May 2026
The global cancer biological therapy market size is expected to increase from USD 124.44 billion in 2025 and is predicted to reach at USD 266.75 billion by 2035, with a solid CAGR of 7.99%.
April 2026
The cancer gene therapy market size was estimated at USD 4.14 billion in 2025 and is projected to hit around USD 22.32 billion by 2035 with a CAGR of 18.35%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
February 2026
The cancer immunotherapy market size is calculated at USD 136.39 billion in 2025 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 6.31 billion in 2024, with a CAGR of 27.92%.
September 2025
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
July 2025
Explore the oncology combination therapy market, driven by rising cancer prevalence, improved treatment efficacy through drug combinations, and advancements in personalized medicine.
June 2026
The global lung cancer surgery market size was evaluated at USD 1.55 billion in 2025 and is predicted to hit around USD 2.76 billion by 2035, growing at a CAGR of 5.95%.
May 2026
The global advanced therapy medicinal products market size is projected to hit around USD 192.67 billion by 2035 increasing from USD 42.04 billion in 2025, with a CAGR of 16.44%.
May 2026
The global next-generation cancer diagnostics market size is projected to hit around USD 46.43 billion by 2035 from USD 19.16 billion in 2025, with a CAGR of 9.25%.
May 2026
The stem cell therapy market size is expected to increase from USD 18.13 billion in 2025 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
May 2026
The global automated and closed cell therapy market size is estimated to hit around USD 12.9 billion by 2035 increasing from USD 1.86 billion in 2025, with a CAGR of 21.37%.
May 2026
The pancreatic cancer market size was estimated at USD 3.25 billion in 2025 and it is expected to be hit around USD 11.47 billion by 2035 at a CAGR of 13.44%.
May 2026
The global CAR T-cell therapy market size is calculated at USD 5,206.15 million in 2025 and is projected to surpass around USD 26,982.3 million by 2035 with a solid CAGR of 17.88%.
May 2026
The global oxygen therapy market size was calculated at USD 41.63 billion in 2025 and is projected to hit around USD 70.01 billion by 2035 with a CAGR of 5.34%.
May 2026
Europe Pharmaceutical CDMO market size is projected to hit around USD 94.94 billion by 2035, rising from USD 45.68 billion in 2025, growing at a CAGR of 7.59%.
May 2026
The global cancer therapeutics market size was evaluated at USD 212.58 billion in 2025 and is expected to surpass around USD 501.07 billion by 2034 with a CAGR of 8.95%.
May 2026
The global cell therapy market size is valued at USD 7.43 billion in 2025 and is projected to hit around USD 55.52 billion by 2035 with a CAGR of 22.28%.
May 2026
The global compounding chemotherapy market size was evaluated at USD 6.92 billion in 2025 and is predicted to surge around USD 13.36 billion by 2035, growing at a CAGR of 6.80%.
May 2026
The global combination antibody therapy market size is estimated to hit around USD 700.59 billion by 2035 increasing from USD 241.03 billion in 2025, with a CAGR of 11.26%.
May 2026
The global active pharmaceutical ingredients CDMO market size is evaluated at USD 116.77 billion in 2025 and is predicted to hit around USD 231.48 billion by 2035, growing at a CAGR of 7.81%.
May 2026
The global gene-replacement therapy market analysis covers market size, growth drivers, key players, pipeline advances, and regulatory trends shaping future demand.
May 2026
The global in vivo CAR-T therapy market size was evaluated at USD 650.00 million in 2025 and is predicted to hit around USD 10,841.07 million by 2035, growing at a CAGR of 32.50%.
May 2026
The global CAR-T therapies for blood cancers market size was evaluated at USD 6.80 billion in 2025 and is predicted to hit around USD 38.40 billion by 2035, growing at a CAGR of 18.90%.
April 2026
The home infusion therapy market size was valued at USD 41.83 billion in 2025 and is projected to hit around USD 90.65 billion by 2035 with a CAGR of 8.04%.
April 2026
The global chemical drug CDMO market size was evaluated at USD 13.20 billion in 2025 and is predicted to hit around USD 29.84 billion by 2035, growing at a CAGR of 8.50%.
April 2026
The global chemical API CDMO market size was evaluated at USD 16.80 billion in 2025 and is predicted to hit around USD 40.88 billion by 2035, growing at a CAGR of 9.30%.
April 2026
The global physical therapy software market size is estimated to hit around USD 4.16 billion by 2035 growing from USD 1.54 billion in 2025, with a solid CAGR of 10.45%.
April 2026
The autologous cell therapy market size was garnered at USD 11.43 billion in 2025 and is expected to hit around USD 60.03 billion by 2035 With a CAGR of 18.04%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com